Obviously Good News, Some laboratories have announced that they have developed an oral vaccine for the new crown virus. Tianjin University Laboratory: an Oral vaccine for new coronavirus has developed
China facing many problems such as downgrade of the market due to the new crown virus. Many people also died due to this virus and thousand of people are effective from this. China try to work to develop the antidote of the coronavirus and they are closer to the success
Jinyun News reports that Tianjin University’s School of Life Sciences professor Jinhai Hai team has announced that they have successfully developed a new oral virus for the coronavirus. In which food-grade safe sclerosis secretes as a carrier. As a target for generating protein antibodies. Professor Jinhai, who has taken oral doses of the new crown vaccine sample 4 times with no side effects.
At the moment, the scientific research team is looking for partners. Hoping to get the vaccine to clinical as soon as possible and to play a role in the prevention and control of epidemic diseases.
Good news! New coronavirus oral vaccine has developed
The new Coronavirus S protein (spike protein) can bind to the host’s viral receptors. It is an important protein that determines the invasion of virus-sensitive cells and is a key target for new coronavirus vaccines and drug development for prevention or treatment.
According to Professor Huang, in addition to the foreign genes of the virus. The expression factor of the vaccine is all fragments of the SCRC’s own gene and does not include resistant genes.
The new coronavirus can bee used as a therapeutic treatment for viral infections, through the high expression of protective antigens, and it can also act as a preventative immune system by activating a preventive immune vaccine mechanism. Its safety, immunization, cost savings and other benefits are exempt. And it is especially suitable for emergency and prevention and control of chronic diseases without traditional vaccines.
Vaccines are a tough and long process from development to market. Currently, the team is reviewing animal toxic, immune efficacy and pilot preparation activities. It’s hoped that eligible businesses and units will cooperate to complete the vaccine testing process and accelerate the development of the vaccine. Clinical validation and popularity will help prevent and control this epidemic.
Zhong Nanshan announces good news! China approved two new coronavirus antibody kits
From the current data, Zhong Nanshan said the outbreak situation in Hubei has started to change. And the absolute number of new cases has decreased. The next big task is to focus on critical patients.
About 2 o’clock yesterday morning, the State Drug Administration approved a number of medicines. One of which is a reagent for the identification of influenza, pyrene influenza and new crown pneumonia, expert educator Zhong revealed.
Education expert Zhong explained. The current epidemic of influenza in the United States covers far more cases than the new crown pneumonia. In fact, China has mixed infections with influenza and new crown pneumonia. Identification of common people, influenza patients and new crown pneumonia patients is essential.
In the meantime, the country also approved two more viable antibody kits. Both of which use colloidal gold, and the LGM antibodies in the body on the seventh day of infection or on the third day after the onset of the disease.
Zhong Nanshan announces good news!
According to a further understanding, one of the kits came from Guangzhou Wan Biotechnology Co., Ltd. Detection reagents for new coronavirus antibodies.
Colloidal gold detector reagent is used to detect the quantitative detection of neutron virus IgM / IgG antibodies in human serum, plasma and whole blood samples in vitro. The operation is simple. The results can be translated from the naked eye within 15 minutes. And this can provide a rapid detection method for suspected neutron pneumonia patients.
In the detection of new coronavirus antibodies, a positive IgM antibody indicates recent infection. And a positive antibody to IgG indicates prolonged infection or previous infection.
In addition, in collaboration with Tsinghua University and Sichuan University West China Hospital. The “Success Response Virus Nucleic Acid Detection Kit”. It was jointly designed and developed under the guidance of educationist Zhong Nanshan. The nucleic acid detection reagent has been approved by the SFDA for its 22nd emergency medical device.
It is a new microfluidic chip system for detecting multiple respiratory tract viruses, which can detect up to 6 types of common respiratory viruses at the same time in 1.5 hours. It including new coronavirus, influenza A virus, and New H1N1 influenza virus (2009), H3N2 included. Influenza virus, influenza B virus, a respiratory virus.